Suven Pharmaceuticals Ltd Share Price

897.65
(1.97%)
Jul 25, 2024|12:59:57 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open872.3
  • Day's High903.9
  • 52 Wk High889.7
  • Prev. Close880.3
  • Day's Low866.2
  • 52 Wk Low481.65
  • Turnover (lac)9,877.48
  • P/E82.25
  • Face Value1
  • Book Value80.76
  • EPS10.7
  • Mkt. Cap (Cr.)22,851.02
  • Div. Yield0
No Records Found

Suven Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

872.3

Prev. Close

880.3

Turnover(Lac.)

9,877.48

Day's High

903.9

Day's Low

866.2

52 Week's High

889.7

52 Week's Low

481.65

Book Value

80.76

Face Value

1

Mkt Cap (₹ Cr.)

22,851.02

P/E

82.25

EPS

10.7

Divi. Yield

0

Suven Pharmaceuticals Ltd Corporate Action

10 Nov 2023

12:00 AM

BookCloser

arrow

9 Nov 2023

12:00 AM

AGM

Announcement Date: 09 Nov, 2023

arrow

12 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Suven Pharmaceuticals Ltd NEWS AND UPDATE

Top 10 stocks for today – 15th July, 2024
15 Jul 2024|08:59 AM

Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Suven Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

25 Jul, 2024|01:24 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 50.10%

Foreign: 50.10%

Indian: 0.00%

Non-Promoter- 27.22%

Institutions: 27.22%

Non-Institutions: 22.67%

Custodian: 0.00%

Share Price

Suven Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

25.46

25.46

25.46

25.46

Preference Capital

0

0

0

0

Reserves

2,030.44

1,723.92

1,495.24

1,039.73

Net Worth

2,055.9

1,749.38

1,520.7

1,065.19

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Revenue

1,320.22

1,009.71

833.78

0

yoy growth (%)

30.75

21.09

0

Raw materials

-399.1

-301.94

-229.18

0

As % of sales

30.23

29.9

27.48

0

Employee costs

-100.48

-76.23

-73.72

0

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

722.44

413.97

357.59

-0.02

Depreciation

-39.09

-31.63

-23.86

0

Tax paid

-164.34

-105.33

-87.51

0

Working capital

215.89

16.14

-52.93

Other operating items

View Cash Flow
Loading...

No Record found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,051.35

1,340.33

1,320.22

1,009.72

833.79

Excise Duty

0

0

0

0

0

Net Sales

1,051.35

1,340.33

1,320.22

1,009.72

833.79

Other Operating Income

0

0

0

0

0

Other Income

61.91

46.36

133.49

67.97

66.33

Suven Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,619.45

127.343,88,632.28867.60.835,536.9998.75

Cipla Ltd

CIPLA

1,503.5

32.691,21,442.631,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,551.6

76.631,20,717.855310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,179.45

34.531,18,680.271,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,820.15

26.551,13,730.311,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Suven Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Company Sec. & Compli. Officer

Hanumantha Rao Kokkonda

Non Executive Director

Shweta Jalan

Independent Director

U B Pravin Rao

Executive Chairman

Annaswamy Vaidheesh

Managing Director

Venkatanaga Kali Vara Prasad Raju Vetukuri

Non Executive Director

Pankaj Patwari

Independent Director

Matangi Gowrishankar

Independent Director

Vinod Rao

Independent Director

K G Ananthakrishnan

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors. Its services include custom synthesis, process R&D, scale-up and contract manufacturing of intermediates, APIs and formulations. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.During the year 2019-20, Suven Life Sciences Ltd. (SLSL) has transferred the CRAMS business undertaking to the Company in accordance with the Scheme of Arrangement (Demerger) approved by the Honble NCLT, Hyderabad Bench now integrated with Contract Development and Manufacturing Operations (CDMO) business model of the Company. In terms of the sanctioned Scheme, the Company issued and allotted 1 (One) fully paid up equity share of face value of Re 1/- (Rupee One only) each of SPL for every 1 (One) fully paid up equity share of face value of Re 1/- (Rupee One only) each held by each shareholder in the Demerged Co
Read More

Company FAQs

What is the Suven Pharmaceuticals Ltd share price today?

Down Arrow

The Suven Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹897.65 today.

What is the Market Cap of Suven Pharmaceuticals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Suven Pharmaceuticals Ltd is ₹22851.02 Cr. as of 25 Jul ‘24

What is the PE and PB ratio of Suven Pharmaceuticals Ltd?

Down Arrow

The PE and PB ratios of Suven Pharmaceuticals Ltd is 82.25 and 10.90 as of 25 Jul ‘24

What is the 52 Week High and Low of Suven Pharmaceuticals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Suven Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Suven Pharmaceuticals Ltd is ₹481.65 and ₹889.7 as of 25 Jul ‘24

What is the CAGR of Suven Pharmaceuticals Ltd?

Down Arrow

Suven Pharmaceuticals Ltd's CAGR for 5 Years at 39.18%, 3 Years at 20.80%, 1 Year at 82.07%, 6 Month at 28.48%, 3 Month at 37.23% and 1 Month at 25.88%.

What is the shareholding pattern of Suven Pharmaceuticals Ltd?

Down Arrow

The shareholding pattern of Suven Pharmaceuticals Ltd is as follows:
Promoters - 50.10 %
Institutions - 27.23 %
Public - 22.67 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.